Nurse Practitioner, Family · Menasha, WI
NPI
1316652373
Since 2023
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1550 Midway Pl
Menasha, WI, 54952
Phone (920) 727-8100
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
268 services
Medicare patients, 2024
121
Average age 69
Drug cost, 2024
$597K
1,159 prescriptions
Company payments, 2025
$2,230
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sarah Bertzyk was code 99214 (office e&m - established), 109 times for 83 patients. In total Sarah Bertzyk billed 268 services in 17 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 109 | 83 | $72.14 | $7,863 |
| 36415 Venipuncture Blood Collection | Office | 49 | 38 | $8.65 | $424 |
| 99215 Office E&M - Established | Office | 26 | 26 | $96.97 | $2,521 |
| 85025 Blood Count | Office | 19 | 14 | $7.61 | $145 |
| 99213 Office E&M - Established | Office | 14 | 14 | $35.94 | $503 |
By year: 2023 $9,375 for 189 services; 2024 $13K for 268 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 49 | 38 | $8.65 | $424 |
| 85025 Blood Count | 19 | 14 | $7.61 | $145 |
Medicare prescription drug claims, 2024
In 2024, the drug Sarah Bertzyk prescribed most often to Medicare patients was Pantoprazole Sodium, with 212 prescriptions and refills. In total Sarah Bertzyk wrote 1,159 Medicare prescriptions that cost $597K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 212 | 473 | 68 | $3,408 |
| Omeprazole Generic | 121 | 310 | 40 | $2,480 |
| Linzess Linaclotide | 73 | 123 | 16 | $68K |
| Ursodiol Generic | 58 | 132 | 14 | $16K |
| Famotidine Generic | 56 | 112 | 19 | $875 |
| Azathioprine Generic | 45 | 125 | 13 | $1,840 |
| Dicyclomine Hcl Generic | 43 | 56 | 15 | $596 |
| Mesalamine Generic | 39 | 79 | Under 11 | $18K |
| Esomeprazole Magnesium Generic | 31 | 55 | Under 11 | $1,045 |
| Mercaptopurine Generic | 25 | 72 | Under 11 | $6,076 |
| Spironolactone Generic | 24 | 60 | Under 11 | $499 |
| Ondansetron Odt Ondansetron | 24 | 24 | Under 11 | $270 |
| Furosemide Generic | 23 | 57 | Under 11 | $197 |
| Budesonide Dr Budesonide | 22 | 58 | 11 | $3,452 |
| Lactulose Generic | 22 | 32 | Under 11 | $649 |
Brand drugs: - claims; generic drugs: 935 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sarah Bertzyk $2,230 ($2,230 in general payments such as food, travel and fees) from 9 companies. The largest payer was Janssen Biotech, Inc. with $750.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 22 | $750 |
| Abbvie Inc. ABBV | 12 | $363 |
| Madrigal Pharmaceuticals MDGL | 9 | $329 |
| Gilead Sciences, Inc. GILD | 9 | $239 |
| Regeneron Healthcare Solutions, Inc. REGN | 13 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $173 |
| Genzyme Corporation SNY | 3 | $80.39 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $55.27 |
| Pfizer Inc. PFE | 1 | $18.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.